|
JUND expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.5080000004275E-07 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.53260000029998E-07 |
| Normal-vs-Stage2 |
1.90679999567678E-08 |
| Normal-vs-Stage3 |
1.50860000047714E-07 |
| Normal-vs-Stage4 |
2.9662000000652E-07 |
| Stage1-vs-Stage2 |
4.096300E-02 |
| Stage1-vs-Stage3 |
4.533800E-01 |
| Stage1-vs-Stage4 |
6.101800E-01 |
| Stage2-vs-Stage3 |
1.911610E-01 |
| Stage2-vs-Stage4 |
2.729600E-01 |
| Stage3-vs-Stage4 |
9.870200E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.68980000051044E-07 |
| Normal-vs-AfricanAmerican |
3.63610000000403E-05 |
| Normal-vs-Asian |
3.68969999997582E-07 |
| Caucasian-vs-AfricanAmerican |
5.528800E-01 |
| Caucasian-vs-Asian |
7.376000E-01 |
| AfricanAmerican-vs-Asian |
4.221800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
9.38080000345565E-08 |
| Normal-vs-Female |
2.02690000006278E-07 |
| Male-vs-Female |
4.478200E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
9.86470000019501E-07 |
| Normal-vs-Age(41-60Yrs) |
7.66440000354862E-08 |
| Normal-vs-Age(61-80Yrs) |
2.25230000205912E-08 |
| Normal-vs-Age(81-100Yrs) |
3.018900E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.101410E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.755560E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.531800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.399400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.649800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.243900E-02 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.169430E-04 |
| Classical-VS-Follicular |
6.738000E-01 |
| Classical-VS-Other |
6.278800E-01 |
| Classical-VS-Normal |
3.80330000049334E-07 |
| Tall-VS-Follicular |
1.892460E-02 |
| Tall-VS-Other |
7.979800E-03 |
| Tall-VS-Normal |
2.27880003755843E-09 |
| Follicular-VS-Other |
5.993800E-01 |
| Follicular-VS-Normal |
4.37830000032946E-07 |
| Other-VS-Normal |
4.187500E-04 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
7.1681000024526E-08 |
| Normal-vs-N1 |
1.56819999999058E-05 |
| N0-vs-N1 |
7.159900E-02 |
|
|
